Allianz RCM Biotechnology Fund add Global Health Sciences | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Allianz RCM Biotechnology Fund add Global Health Sciences

Sort by

Viewing results 1‒25 of 40

The Big Read
How UK regulators are missing a chance to make the best of Brexit
...The bottleneck, according to Pardoe, is caused by regulators who are failing to compete in a global marketplace for talent and funds....
February 27, 2024
The Big Read
The Biden administration takes on the US drugs industry
...Suerie Moon, co-director of the global health centre at Geneva’s Graduate Institute, says US health officials had chosen the list of 10 drugs for negotiation carefully....
September 18, 2023
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
FT Wealth
‘Biotech is the ultimate impact investment’ — family offices can’t get enough of it
...As well as longevity medicine, Korify focuses on mental health....
May 15, 2023
The Big Read
The UK’s dream of becoming a ‘science superpower’
...The UK will add £200mn through a life sciences investment programme. The state-backed British Business Bank is overseeing the fund....
January 5, 2023
News in-depthUK economy
FT economists survey: ‘anaemic’ economy needs ‘investment, investment, investment’
...contracts will undermine how people feel about health....
January 2, 2024
Disrupted Times
US jobs data clouds outlook for Federal Reserve
...Science round-up Scientists warned a global conference on human genome editing that urgent action was needed to cut the cost of gene treatments for once incurable diseases....
March 10, 2023
FT Live
Global Wealth Management Summit
Recalibrating business for multi-generational private clients
Wednesday, 6 November222 Marylebone Road, London NW1 6JQ, United Kingdom
The crisis in European equities
Britain’s ‘capitalism without capital’: the pension funds that shun risk
...Immunocore is a success story for the UK’s ambitions in biotechnology....
April 19, 2023
FT SeriesLeading in a crisis
Moderna’s Noubar Afeyan on the race to create a Covid vaccine
...They agreed on the call that they would join what became a global race to develop a Covid vaccine....
July 10, 2022
Special ReportFT Health: Innovation in Healthcare
Finance, culture, talent: why Europe struggles to commercialise its biotech expertise
...The three largest US biotech funds are twice the size of their European counterparts, with a collective value of about $12bn, the report adds....
March 21, 2022
Vienna
Vienna’s tech success stories boost city’s start-up culture
...“Vienna and Linz have both experienced a change of narrative in the last decade, turning into more technologically focused hubs with key verticals like biotechnology, digital health, educational technology...
December 17, 2021
News in-depthCapital markets
‘Just not functioning’: quotes from a tumultuous year in markets
...‘A lot of people need cash and they’re liquidating the only thing that they can’ Mike Riddell of Allianz Global Investors March 18: Supposedly safe government bonds endure periods of indiscriminate selling...
December 30, 2020
News in-depthThe Big Read
Covid vaccines offer Big Pharma a chance of rehabilitation
...There is no suggestion that the phase 3 trials themselves have been other than robust, but “going so fast to phase 3 would not be acceptable outside a public health emergency”, he adds....
November 27, 2020
Simon Edelsten
Are US stocks too pricey for UK investors?
...Simon Edelsten is co-manager of the Artemis Global Select Fund and the Mid Wynd International Investment Trust....
February 26, 2021
The Big Read
Big Meat: facing up to the demands for sustainability
...Robbie Miles, a fund manager overseeing sustainable food investments at Allianz, says: “The oil industry got it wrong, obfuscating the science,” and “not embracing change that needed to happen”....
January 17, 2021
Special ReportFT Health: Combating Coronavirus
Coronavirus puts Big Pharma’s IP regime to the test
...Companies have quickly learned, however, that they will face a furious public backlash if they are seen to be aggressively asserting patents during a global health crisis....
April 21, 2020
FT Live
Global Private Banking Awards 2024
Celebrating excellence in wealth management
Thursday, 7 NovemberThe Landmark London, London, UK
FT Magazine
How unlocking the secrets of African DNA could change the world
...Health at NIH....
March 5, 2020
News in-depthThe Big Read
The Apple effect: Germany fears being left behind by Big Tech
...In the US, big pension funds have long invested in technology start-ups via venture capital, whereas in Germany pension funds tend to be ultra-conservative and place the bulk of their investments in low-yielding...
January 29, 2020
Special ReportBoldness in Business
Business success is about serving basic human needs
...The town’s businesses and professionals are easy enough to add to our picture....
March 30, 2020
Equities
Markets Now - LIVE - Thursday 12th March 2020
...Twice delayed full-year results from the reit basket case add little new to the recent trading update that came with its scrapped rescue rights issue, other than an auditor’s warning....
March 12, 2020
The FT guide to a longer (and healthier) life
Laura Deming: ‘I wanted to work on the world’s most important problem’
...The fund’s first investment, in Unity Biotechnology, helped her to do that. Unity is developing a drug that targets senescent cells — decrepit cells that refuse to die....
May 31, 2019
News in-depthThe Big Read
Gene editing: how agritech is fighting to shape the food we eat
...He adds that many medicines generally accepted by the public, including insulin, are produced by genetically engineered organisms....
February 10, 2019
Special Report50 Ideas to Change the World
Nanobots kill off cancerous tumours as fiction becomes reality
...funds....
March 5, 2018
Fund management
Biotech investors still feeling the pain
...However, he adds that, given current market conditions, HBM will focus on private investments, to enable it to ask for fuller information about the science behind drug developments....
July 31, 2016
Law
The FT Global General Counsel 30
...Luckily he works for a global maker of rubber gloves....
June 21, 2016
FT Magazine
University challenge: the race for money, students and status
...They are also turning to new avenues to raise funds....
June 23, 2016

Previous pagePage 1 of 2Next page